{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:58:03Z","timestamp":1793609883096,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jinf.2024.106183","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T15:22:34Z","timestamp":1715700154000},"page":"106183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: A systematic review and meta-analysis of aggregated participant data"],"prefix":"10.1016","volume":"89","author":[{"given":"Xinyi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyue","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0877-0424","authenticated-orcid":false,"given":"Chaojie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanquan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohai","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5094-3195","authenticated-orcid":false,"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinkun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guobao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6201-4318","authenticated-orcid":false,"given":"Lianping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jinf.2024.106183_bib1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-020-0395-y","article-title":"Antimicrobial use, drug-resistant infections and COVID-19","volume":"18","author":"Rawson","year":"2020","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"10.1016\/j.jinf.2024.106183_bib2","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S2214-109X(20)30444-7","article-title":"COVID-19 pneumonia and the appropriate use of antibiotics","volume":"8","author":"Ginsburg","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"8","key":"10.1016\/j.jinf.2024.106183_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(23)00124-X","article-title":"How can lessons from the COVID-19 pandemic enhance antimicrobial resistance surveillance and stewardship?","volume":"23","author":"Walia","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2024.106183_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaa098","article-title":"COVID-19 will further exacerbate global antimicrobial resistance","volume":"27","author":"Yam","year":"2020","journal-title":"J Travel Med"},{"issue":"6","key":"10.1016\/j.jinf.2024.106183_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004240","article-title":"Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance: a modelling study","volume":"20","author":"Smith","year":"2023","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.jinf.2024.106183_bib6","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S1473-3099(22)00866-0","article-title":"Too many antibiotics for patients with COVID-19 despite low bacterial infections","volume":"23","author":"Giacobbe","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2024.106183_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S2666-5247(22)00355-X","article-title":"Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis","volume":"4","author":"Langford","year":"2023","journal-title":"Lancet Microbe"},{"issue":"1","key":"10.1016\/j.jinf.2024.106183_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13756-022-01085-z","article-title":"Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021)","volume":"11","author":"Kariyawasam","year":"2022","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"10.1016\/j.jinf.2024.106183_bib9","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cmi.2020.12.018","article-title":"Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis","volume":"27","author":"Langford","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.jinf.2024.106183_bib10","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","article-title":"Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis","volume":"26","author":"Langford","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.jinf.2024.106183_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20563","article-title":"Overprescription of antibiotics for treating hospitalized COVID-19 patients: a systematic review & meta-analysis","volume":"9","author":"Rabbi","year":"2023","journal-title":"Heliyon"},{"issue":"8","key":"10.1016\/j.jinf.2024.106183_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272375","article-title":"Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: a systematic review and meta-analysis","volume":"17","author":"Alshaikh","year":"2022","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jinf.2024.106183_bib13","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S2666-5247(23)00111-8","article-title":"Tachykinins and the potential causal factors for post-COVID-19 condition","volume":"4","author":"Janket","year":"2023","journal-title":"Lancet Microbe"},{"issue":"7873","key":"10.1016\/j.jinf.2024.106183_bib14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41586-021-03792-w","article-title":"After the pandemic: perspectives on the future trajectory of COVID-19","volume":"596","author":"Telenti","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jinf.2024.106183_bib15","unstructured":"JR VMAMBNCSHLMLSPSTSKTAT. Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions. Agency for healthcare research and quality methods guide for comparative effectiveness reviews. AHRQ Publication 2012; No. 12-EHC047-EF."},{"issue":"1","key":"10.1016\/j.jinf.2024.106183_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1473-3099(17)30724-7","article-title":"Classifying antibiotics in the WHO essential medicines list for optimal use-be AWaRe","volume":"18","author":"Sharland","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2024.106183_bib17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1192\/bjp.2022.79","article-title":"The impact of the COVID-19 pandemic on presentations to health services following self-harm: systematic review","volume":"221","author":"Steeg","year":"2022","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jinf.2024.106183_bib18","doi-asserted-by":"crossref","DOI":"10.7189\/iogh.13.06006","article-title":"Health system adaptions to improve care for people living with non-communicable diseases during COVID-19 in low-middle income countries: a scoping review","volume":"13","author":"Baatiema","year":"2023","journal-title":"J Glob Health"},{"issue":"1","key":"10.1016\/j.jinf.2024.106183_bib19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/22221751.2022.2030196","article-title":"Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis","volume":"11","author":"Ayobami","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jinf.2024.106183_bib20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijid.2020.12.087","article-title":"Antibiotics and antimicrobial resistance in the COVID-19 era: perspective from resource-limited settings","volume":"104","author":"Lucien","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2024.106183_bib21","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamainternmed.2020.3539","article-title":"Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy","volume":"180","author":"Grasselli","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.jinf.2024.106183_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13756-020-00871-x","article-title":"Infections and antimicrobial resistance in intensive care units in lower-middle income countries: a scoping review","volume":"10","author":"Saharman","year":"2021","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"10.1016\/j.jinf.2024.106183_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12941-023-00641-8","article-title":"Extended-spectrum \u03b2-lactamase- producing gram-negative bacterial infections in severely ill COVID-19 patients admitted in a national referral hospital, Kenya","volume":"22","author":"Mutua","year":"2023","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"4","key":"10.1016\/j.jinf.2024.106183_bib24","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/jac\/dkab495","article-title":"Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: an observational study from Italy, 2020-21","volume":"77","author":"Falcone","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2024.106183_bib25","first-page":"S188","article-title":"Prevalence of coinfections with ESKAPE pathogens in COVID-19 patients: a review","volume":"10","author":"Poyil","year":"2021","journal-title":"Ann Phytomed\u2014Int J"},{"issue":"11","key":"10.1016\/j.jinf.2024.106183_bib26","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/S1473-3099(22)00683-1","article-title":"The WHO AWaRe antibiotic book: providing guidance on optimal use and informing policy","volume":"22","author":"Sharland","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2024.106183_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics10060745","article-title":"Antimicrobial use in COVID-19 patients in the first phase of the SARS-CoV-2 pandemic: a scoping review","volume":"10","author":"Cong","year":"2021","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.jinf.2024.106183_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2258","article-title":"Efficacy and safety of azithromycin in Covid-19 patients: a systematic review and meta-analysis of randomized clinical trials","volume":"32","author":"Kamel","year":"2022","journal-title":"Rev Med Virol"},{"issue":"1","key":"10.1016\/j.jinf.2024.106183_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cmi.2020.08.022","article-title":"Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis","volume":"27","author":"Fiolet","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"10274","key":"10.1016\/j.jinf.2024.106183_bib30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(21)00149-5","article-title":"Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2024.106183_bib31","doi-asserted-by":"crossref","first-page":"n1038","DOI":"10.1136\/bmj.n1038","article-title":"Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study","volume":"373","author":"Prats-Uribe","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jinf.2024.106183_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101738","article-title":"Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France","volume":"35","author":"Million","year":"2020","journal-title":"Travel Med Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2024.106183_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics10080935","article-title":"Antibiotics prescribing in intensive care settings during the COVID-19 era: a systematic review","volume":"10","author":"Abu-Rub","year":"2021","journal-title":"Antibiotics"},{"issue":"8","key":"10.1016\/j.jinf.2024.106183_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11080991","article-title":"Antibiotic use and bacterial infection in COVID-19 patients in the second phase of the SARS-CoV-2 pandemic: a scoping review","volume":"11","author":"Cong","year":"2022","journal-title":"Antibiotics"},{"issue":"3","key":"10.1016\/j.jinf.2024.106183_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001579","article-title":"Analysis of multiple bacterial species and antibiotic classes reveals large variation in the association between seasonal antibiotic use and resistance","volume":"20","author":"Sun","year":"2022","journal-title":"PLoS Biol"},{"issue":"7","key":"10.1016\/j.jinf.2024.106183_bib36","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/319604","article-title":"Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae","volume":"32","author":"Lipsitch","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2024.106183_bib37","first-page":"1","article-title":"Prevalence of antibiotics prescription amongst patients with and without COVID-19 in low- and middle-income countries: a systematic review and meta-analysis","author":"Satria","year":"2022","journal-title":"Pathog Glob Health"},{"issue":"4","key":"10.1016\/j.jinf.2024.106183_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106409","article-title":"Antimicrobial stewardship in the ICU in COVID-19 times: the known unknowns","volume":"58","author":"Schouten","year":"2021","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"10.1016\/j.jinf.2024.106183_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics10080935","article-title":"Antibiotics prescribing in intensive care settings during the COVID-19 era: a systematic review","volume":"10","author":"Abu-Rub","year":"2021","journal-title":"Antibiotics"},{"issue":"6","key":"10.1016\/j.jinf.2024.106183_bib40","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/myc.13447","article-title":"Prevalence, risk factors, treatment and outcome of multidrug resistance Candida auris infections in Coronavirus disease (COVID-19) patients: a systematic review","volume":"65","author":"Vinayagamoorthy","year":"2022","journal-title":"Mycoses"},{"issue":"10","key":"10.1016\/j.jinf.2024.106183_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10102067","article-title":"Carbapenem-Resistant Klebsiella pneumoniae infections in ICU COVID-19 patients-a scoping review","volume":"10","author":"M\u0119drzycka-D\u0105browska","year":"2021","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.jinf.2024.106183_bib42","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s15010-021-01602-z","article-title":"State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia","volume":"49","author":"Chong","year":"2021","journal-title":"Infection"},{"issue":"9","key":"10.1016\/j.jinf.2024.106183_bib43","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/cid\/ciaa530","article-title":"Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing","volume":"71","author":"Rawson","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.jinf.2024.106183_bib44","article-title":"Bacterial co-infection in patients with COVID-19 hospitalized (ICU and Not ICU): review and meta-analysis","volume":"11","author":"Santos","year":"2022","journal-title":"Antibiot-Basel"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324001178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324001178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:03:14Z","timestamp":1731974594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445324001178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0163445324001178"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106183","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: A systematic review and meta-analysis of aggregated participant data","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106183"}}